W-shaped permeability evolution of coal with supercritical CO2 phase transition
Not provided.
SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Not provided.
SNL’s IDC Reengineering Phase 2 team developed 12 Use Case Realizations (UCRs) during the Elaboration phase. This document describes the changes made to these UCRs after their initial delivery to the IDC.
The Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO) operates the International Data Centre (IDC) to support treaty verification activities by Member States. The IDC collects, stores, processes, and distributes data from seismic, hydroacoustic, infrasound, and radionuclide stations. A significant component of the IDC is the seismic, hydroacoustic, and infrasound (SHI) processing system. The IDC has recognized the need to reengineer the SHI processing system and has defined a three-phase reengineering effort. IDC Reengineering Phase 1 (RP1) started in 2011 with the goal to significantly modernize SHI automatic and interactive data processing software, focusing on enhancements to individual components of the system. Reengineering Phase 2 (RP2), started in 2014, addresses the task of specifying a unified architecture for all SHI software, across processing stages, to pave the way for further software development and sustainment in the future. A key objective of RP2 is an architecture sufficient to provide a basis for a cost estimate for the development or enhancement of the software components and subsystems. This report provides a brief description of the scope of the IDC Reengineering Phase 2 project. It describes the goals and objectives of reengineering, the system definition, and the technical scope of the system.This report expands upon the “Scope for IDC Reengineering Phase 2”, July 2014, ECS-DIS-WGB-43-PTS-MATERIAL-12-ADD-1, produced by the IDC.
Purpose: To assess the safety and efficacy of combining oncolytic adenovirus-mediated cytotoxic gene therapy (OAMCGT) with intensity modulated radiation therapy (IMRT) in intermediate-risk prostate cancer. Methods and Materials: Forty-four men with intermediate-risk prostate cancer were randomly assigned to receive either OAMCGT plus IMRT (arm 1; n=21) or IMRT only (arm 2; n=23). The primary phase 2 endpoint was acute (≤90 days) toxicity. Secondary endpoints included quality of life (QOL), prostate biopsy (12-core) positivity at 2 years, freedom from biochemical/clinical failure (FFF), freedom from metastases, and survival. Results: Men in arm 1 exhibited a greater incidence of low-grade influenza-like symptoms, transaminitis, neutropenia, and thrombocytopenia than men in arm 2. There were no significant differences in gastrointestinal or genitourinary events or QOL between the 2 arms. Two-year prostate biopsies were obtained from 37 men (84%). Thirty-three percent of men in arm 1 were biopsy-positive versus 58% in arm 2, representing a 42% relative reduction in biopsy positivity in the investigational arm (P=.13). There was a 60% relative reduction in biopsy positivity in the investigational arm in men with <50% positive biopsy cores at baseline (P=.07). To date, 1 patient in each arm exhibited biochemical failure (arm 1, 4.8%; arm 2, 4.3%). No patient developed hormone-refractory or metastatic disease, and none has died from prostate cancer. Conclusions: Combining OAMCGT with IMRT does not exacerbate the most common side effects of prostate radiation therapy and suggests a clinically meaningful reduction in positive biopsy results at 2 years in men with intermediate-risk prostate cancer.
Developing methods to understand and control defect formation in nanomaterials offers a promising route for materials discovery. Monolayer MX 2 phases represent a particularly compelling case for defect engineering of nanomaterials due to the large variability in their physical properties as different defects are introduced into their structure. However, effective identification and quantification of defects remain a challenge even as high-throughput scanning transmission electron microscopy methods improve. This study highlights the benefits of employing first principles calculations to produce digital twins for training deep learning segmentation models for defect identification in monolayer MX 2 phases. Around 600 defect structures were obtained using density functional theory calculations, with each monolayer MX 2 structure being subjected to multislice simulations for the purpose of generating the digital twins. Several deep learning segmentation architectures were trained on this dataset, and their performances evaluated under a variety of conditions such as recognizing defects in the presence of unidentified impurities, beam damage, grain boundaries, and with reduced image quality from low electron doses. Further, this digital twin approach allows benchmarking different deep learning architectures on a theory dataset, which enables the study of defect classification under a broad array of finely controlled conditions. It thus opens the door to resolving the underpinning physical reasons for model shortcomings and potentially chart paths forward for automated discovery of materials defect phases in experiments.
This fact sheet is a basic overview of the Western Wind and Solar Integration Study, Phase 2. The electric grid is a highly complex, interconnected machine, and changing one part of the grid can have consequences elsewhere. Adding wind and solar affects the operation of the other power plants and adding high penetrations can induce cycling of fossil-fueled generators. Cycling leads to wear-and-tear costs and changes in emissions.
In this Phase 2 SBIR program, Vista Clara successfully developed and field-tested small diameter NNR logging tools for subsurface characterization and monitoring. This effort involved the design and development surface electronics, a winch with 470ft cable, and three interchangeable downhole probes: a 3.5â diameter borehole NMR probe, a 1.67â diameter borehole NMR probe, and a 2.5â diameter NMR probe that can be deployed using a Geoprobe direct push machine. The 3.5â probe was tested extensively over a 6 week period including 4â to 8â boreholes in Washington, Idaho, Nebraska, Colorado, Kansas, Connecticut and Massachusetts. The field test campaign was highly successful. The 1.67â probe was assembled, tested and calibrated in the laboratory. The 2.5â Geoprobe probe is in final assembly and testing at the time of this report. The completed Phase 2 R&D program has resulted in the first NMR logging tool that can be deployed in boreholes of 4â diameter, the first NMR logging tool that can be deployed in boreholes on 2â diameter, and the first NMR logging tool that can be deployed by a direct push machine. These small diameter tools make NMR logging technically and economically feasible, for the first time. Previously available NMR logging tools were developed for oilfield applications and are prohibitively large and expensive for the majority of near surface groundwater characterization problems.
This report provides a summary of all key technical activities completed during the performance of the Framatome Enhanced Accident Tolerant Fuel (EATF) Phase 2 project under the Department of Energy (DOE) grant DE-NE0008220. The earlier Phase 1B portion of the EATF project which was also part of this grant was reported earlier in Reference [1]. This report covers activities during the first two years of the EATF Phase 2 program and together with Reference [1], represents the final scientific/technical report required to be submitted at the end of a contract. It should be noted that much of the work here remains in progress and will continue under a new DOE grant, DE-NE0008818.
Purpose: A previous phase 1 study suggested that definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) is tolerable and active in patients with advanced esophageal cancer (AEC). This phase 2 study was designed to confirm the efficacy and toxicity of DCF-R in AEC. Methods and Materials: Patients with previously untreated thoracic AEC who had T4 tumors or M1 lymph node metastasis (M1 LYM), or both, received intravenous infusions of docetaxel (35 mg/m{sup 2}) and cisplatin (40 mg/m{sup 2}) on day 1 and a continuous intravenous infusion of 5-fluorouracil (400 mg/m{sup 2}/day) on days 1 to 5, every 2 weeks, plus concurrent radiation. The total radiation dose was initially 61.2 Gy but was lowered to multiple-field irradiation with 50.4 Gy to decrease esophagitis and late toxicity. Consequently, the number of cycles of DCF administered during radiation therapy was reduced from 4 to 3. The primary endpoint was the clinical complete response (cCR) rate. Results: Characteristics of the 42 subjects were: median age, 62 years; performance status, 0 in 14, 1 in 25, 2 in 3; TNM classification, T4M0 in 20, non-T4M1LYM in 12, T4M1LYM in 10; total scheduled radiation dose: 61.2 Gy in 12, 50.4 Gy in 30. The cCR rate was 52.4% (95% confidence interval [CI]: 37.3%-67.5%) overall, 33.3% in the 61.2-Gy group, and 60.0% in the 50.4-Gy group. The median progression-free survival was 11.1 months, and the median survival was 29.0 months with a survival rate of 43.9% at 3 years. Grade 3 or higher major toxicity consisted of leukopenia (71.4%), neutropenia (57.2%), anemia (16.7%), febrile neutropenia (38.1%), anorexia (31.0%), and esophagitis (28.6%). Conclusions: DCF-R frequently caused myelosuppression and esophagitis but was highly active and suggested to be a promising regimen in AEC. On the basis of efficacy and safety, a radiation dose of 50.4 Gy is recommended for further studies of DCF-R.
The goal of Phase 2 the OSD ATL Contingency Contractor Optimization project is to create a prototype of a tool for the contingency contractor element of total force planning during the Support for Strategic Analysis (SSA). An optimization model was developed to determine the optimal mix of military, Department of Defense (DoD) civilians and contractors that accomplishes a set of user defined mission requirements at the lowest possible cost while honoring resource limitations and manpower use rules. Additional features allow the model to understand the variability of the Total Force Mix when there is uncertainty in mission requirements and recommend where investments in manpower capabilities might minimize the overall total force costs in future operations.
Supplemental chemical composition data are provided for a series of simulated low-activity waste glasses designated as the Phase 2, Outer Layer study. The glasses were selected and fabricated by the Pacific Northwest National Laboratory in support of property/composition model development for operation of the Hanford Tank Waste Treatment and Immobilization Plant. Additional characterization of glasses in this series is described in SRNL-STI-2018-00150, “Sulfur Solubility Testing and Characterization of Hanford LAW Phase 2, Outer Layer Matrix Glasses.” The measured concentrations of SO 3 reported here are generally lower than those measured for the earlier versions of these sulfur saturated glasses.
This report presents updated material score cards with detailed justification of the proposed rating provided and quantifies the readiness of the advanced manufacturing of materials for nuclear applications. Based on an expanded literature review of available data, the scores in this report (Phase 2) have either been modified or remained constant as compared with Phase 1 scoring. The rating justification are provided for each scoring criteria whereas the maturity quantification of additively manufactured alloys and the knowledge gaps are discussed with reference traceability. This report focuses on the detailed justification and traceability for the adoption of additively manufactured 316SS, SS304, Alloy 800H, Graphite C/C, Alloy N, Silicon Carbide, HT9, Alloy 617, and Alloy 718. Significant variability in data and knowledge gaps exist among the identified materials. The scorecards are therefore based on published literature data, industry response to a survey, stakeholder input collected at workshops, and expert opinion. The interpretation and assessment were somewhat challenged as experimental process parameters and methodology varied and best judgment was exercised for score quantification. This assessment reflects the overall level of technical maturity for AM materials and their deployment in Gen-VI nuclear systems. These Phase 2 scorecards are likely to be revised based on additional input from stakeholders and as new research results become available.
Purpose: A prospective phase 2 multicenter trial was performed to investigate the efficacy and safety of preoperative short-course concurrent chemoradiation therapy (CRT) followed by delayed surgery for patients with locally advanced rectal cancer. Methods and Materials: Seventy-three patients with cT3-4 rectal cancer were enrolled. Radiation therapy of 25 Gy in 5 fractions was delivered over 5 consecutive days using helical tomotherapy. Concurrent chemotherapy was administered on the same 5 days with intravenous bolus injection of 5-fluorouracil (400 mg/m{sup 2}/day) and leucovorin (20 mg/m{sup 2}/day). After 4 to 8 weeks, total mesorectal excision was performed. The primary endpoint was the pathologic downstaging (ypStage 0-I) rate, and secondary endpoints included tumor regression grade, tumor volume reduction rate, and toxicity. Results: Seventy-one patients completed the planned preoperative CRT and surgery. Downstaging occurred in 20 (28.2%) patients, including 1 (1.4%) with a pathologic complete response. Favorable tumor regression (grade 4-3) was observed in 4 (5.6%) patients, and the mean tumor volume reduction rate was 62.5 ± 21.3%. Severe (grade ≥3) treatment toxicities were reported in 27 (38%) patients from CRT until 3 months after surgery. Conclusions: Preoperative short-course concurrent CRT followed by delayed surgery for patients with locally advanced rectal cancer demonstrated poor pathologic responses compared with conventional long-course CRT, and it yielded considerable toxicities despite the use of an advanced radiation therapy technique.
We report long-term outcomes of phase 2 trial on patients with invasive breast cancer treated with accelerated partial-breast irradiation (APBI) using tomotherapy after breast conservative surgery.
SNL’s IDC Reengineering Phase 2 team developed 31 Use Cases (UCs) during the E3 Elaboration Iteration. This document describes the changes made to these UCs after their initial delivery to the IDC in October 2016.
The Phase-2 upgrade of the Large Hadron Collider (LHC), also known as the High-Luminosity LHC (HL-LHC) is designed to achieve peak instantaneous luminosities which is about an order of magnitude higher than the nominal design value of $10^{34}~cm^{-2}s^{-1}$ delivering a total of atleast $3000 fb^{-1}$ data over 10 years of operation at $\sqrt{s}~=~14~TeV$. One crucial aspect of the CMS Phase-2 detector upgrade is the replacement of the existing tracking detector in order to deal with the extreme HL-LHC conditions, retaining and further expanding the physics performances achieved in the previous years. The outer part of the upgraded tracker (OT), will be equipped with over 13,000 macro Pixel-Strip (PS) and Strip-Strip (2S) modules! Module production is distributed across centers worldwide and necessitates coordinated efforts and standardized procedures. Along with production and assembly of the modules, Fermilab OT group is also working on a tool, Phase 2 Outer Tracker Analyzer of Test Outputs (POTATO) that will analyze, grade, upload and manage the large quantity of files to be stored in the centralized Database (DB). In this contribution a brief overview of the module testing and the power and dire need of POTATO to handle this large number of test outputs will be presented.
Phase 1 of the Tank-Farm Vadose Zone Program (TFVZP) developed information on the nature and extent of vadose zone contamination in the tank farms through field studies, laboratory analyses and experiments, and historical data searches; assembled data and performed tank-farm risk analysis; and initiated interim corrective actions to lessen the impacts of tank leak contaminants. Pacific Northwest National Laboratory scientists and external collaborators at universities and U.S. Department of Energy user facilities sampled and analyzed contaminant plumes. These types of activities will continue during Phase 2 of the TFVZP to refine and expand scientific understanding of the subsurface beneath tank farms, especially of water movement, residual waste leaching, and contaminant transport.
The Phase-2 upgrade of the Large Hadron Collider (LHC), also known as the High-Luminosity LHC (HL-LHC) is designed to achieve peak instantaneous luminosities which is about an order of magnitude higher than the nominal design value of $10^{34}~cm^{-2}s^{-1}$ delivering a total of atleast $3000 fb^{-1}$ data over 10 years of operation at $\sqrt{s}~=~14~TeV$. One crucial aspect of the CMS Phase-2 detector upgrade is the replacement of the existing tracking detector in order to deal with the extreme HL-LHC conditions, retaining and further expanding the physics performances achieved in the previous years. The outer part of the upgraded tracker (OT), will be equipped with over 13,000 macro Pixel-Strip (PS) and Strip-Strip (2S) modules! Module production is distributed across centers worldwide and necessitates coordinated efforts and standardized procedures. Along with production and assembly of the modules, Fermilab OT group is also working on a tool, Phase 2 Outer Tracker Analyzer of Test Outputs (POTATO) that will analyze, grade, upload and manage the large quantity of files to be stored in the centralized Database (DB). In this contribution a brief overview of the module testing and the power and dire need of POTATO to handle this large number of test outputs will be presented.